Similar Papers

Paper Title
Journal
Date
Author
Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)
Jennifer A Woyach ... Amy J Johnson
Blood | VOL. 123
Jennifer A Woyach, et. al.Jennifer A Woyach ... Amy J Johnson
20 Feb 2014
Exploring the Functional Relevance of BTK Beyond Chronic Lymphocytic Leukemia (CLL) Cells: BTK Expression in Non-Malignant Immune Cells of the Microenvironment Mediates CLL Development and Progression In Vivo
Fabienne Mcclanahan ... Jennifer A Woyach
Blood | VOL. 128
Fabienne Mcclanahan, et. al.Fabienne Mcclanahan ... Jennifer A Woyach
02 Dec 2016
Initial Findings from a First-in-Human Phase 1a/b Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients with Relapsed/Refractory B Cell Malignancies
Emma Searle ... Graham P Collins
Blood | VOL. 142
Emma Searle, et. al.Emma Searle ... Graham P Collins
02 Nov 2023
Abstract 791: CG'806, a first-in-class pan-FLT3/pan-BTK inhibitor, demonstrates superiority to other FLT3 and BTK inhibitors against primary patient samples
Stephen E Kurtz ... Beth Wilmot
Cancer Research | VOL. 78
Stephen E Kurtz, et. al.Stephen E Kurtz ... Beth Wilmot
01 Jul 2018
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Are you ready for it? VEN-HMA for younger patients with AML.
Tara L Lin
Blood | VOL. 145
Tara L LinTara L Lin
29 May 2025
Unveiling the enigma: circulating flowerlike large B-lymphoma cells in the context of angioimmunoblastic T-cell lymphoma.
Bhaumik Shah ... Reza Nejati
Blood | VOL. 145
Bhaumik Shah, et. al.Bhaumik Shah ... Reza Nejati
29 May 2025
Primary myelofibrosis involving lymph nodes with the same mutational profile in bone marrow.
Yanna Ding ... Kikkeri N Naresh
Blood | VOL. 145
Yanna Ding, et. al.Yanna Ding ... Kikkeri N Naresh
29 May 2025
"Scotty, we need more power!"
Kelvin Lee
Blood | VOL. 145
Kelvin LeeKelvin Lee
29 May 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.